BONIFACIO, Massimiliano
BONIFACIO, Massimiliano
DIPARTIMENTO DI INGEGNERIA PER LA MEDICINA DI INNOVAZIONE
A critical comparison of Sokal, Euro, and Eutos risk scores in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors.
2015-01-01 Baccarani, M; Castagnetti, F; Gugliotta, G; Breccia, M; Iurlo, A; Levato, L; Abruzzese, A; Stagno, F; Bonifacio, Massimiliano; Gozzini, A; Pregno, P; Binotto, G; Annunziata, M; Galieni, P; Fava, C; Bocchia, M; Gobbi, M; Russo, D; Specchia, G; Soverini, S; Alimena, G; Martinelli, G; Pane, F; Saglio, G; Rosti, G.
A simple score predicts clonal mast cell disorders in patients with systemic reactions to Hymenoptera venom without skin lesions
2013-01-01 Bonifacio, Massimiliano; Bonadonna, Patrizia; Caimmi, C; Carli, G; Artuso, Anna; Lombardo, C; Perbellini, Omar; de Matteis, G; Pizzolo, G; Zanotti, Roberta
A study of the crosstalk between CD30 and CXCR4
2008-01-01 Bonifacio, Massimiliano; Rigo, Antonella; Pizzolo, Giovanni; Vinante, Fabrizio
A Survey on Clinical and Biological Characteristic and Therapy Management of an Italian Series of 455 Adult Patients with Systemic Mastocytosis on Behalf of Italian Registry of Mastocytosis
2014-01-01 Lisa, Pieri; Bonadonna, Patrizia; Chiara, Elena; Cristina, Papayannidis; Federica Irene, Grifoni; Michela, Rondoni; Stefania, Girlanda; Marina, Mauro; Diomira, Magliacane; Elena Maria, Elli; Maria Loredana, Iorno; Maurizio, Severino; Fabio, Almerigogna; Federica, Scarfì; Bonifacio, Massimiliano; Perbellini, Omar; Artuso, Anna; Simona, Soverini; Caterina De, Benedittis; Simona, Muratori; Luisa, Lunardon; Vittoria, Cova; Gabriele, Cortellini; Alberto, Bosi; Agostino, Cortelezzi; Giovanni, Martinelli; Massimo, Triggiani; Serena, Merante; Alessandro Maria, Vannucchi; Zanotti, Roberta
ALK-positive anaplastic large cell lymphoma with PAX-5 expression: report of a case
2011-01-01 Zamo', Alberto; Munari, Enrico; Bertolaso, Anna; Bonifacio, Massimiliano; Chilosi, Marco
Back to life – Living, treating, managing myelofibrosis: the burden of illness for patients and their families
2014-01-01 Marini, Mg; Cappuccio, A; Abruzzese, A; Carella, A; Lunghi, M; Loiacono, I; Palumbo, G; Bonifacio, Massimiliano; Cilloni, D; Iurlo, A; Andriani, A; Benevolo, G; Minoia, C; Turri, D; Elli, Em; Falcone, Ap; Anaclerico, B; Traficante, A; Di Renzo, N; Tiribelli, M; Calistri, E; Zambello, R; Spinosa, C; Riccò, A; Palandri, F; Raucci, L; Martino, B; Annunziata, M; D’Alosio, M; Liberati, Am; Caocci, G; Maffioli, M; Breccia, M; Pugliese, N; Betti, S; Giglio, G; Reale, L.
BCR-ABL fusion transcript b2a2 is associated with a higher risk of non-optimal early response in CP-CML patients treated with standard dose imatinib: a study from Gruppo Triveneto LMC.
2016-01-01 G., Binotto; M., Tiribelli; Bonifacio, Massimiliano; L., Frison; M., Narbergoj; F., De Marchi; Scaffidi, Luigi; M., Medeot; E., Maino; E., Calistri; A., Bonalumi; Krampera, Mauro; Ambrosetti, Achille; R., Fanin; G., Semenzato
BCR-ABL mutations in chronic myeloid leukemia (CML) patients (pts) with failure and warning to first- and second-lline tyrosine kinase inhibitor (TKI) therapy: what is the advantage of Next-Generation Sequencing (NGS) over conventional sequencing?
2015-01-01 Soverini, S; De Benedittis, C; Castagnetti, F; Gugliotta, G; Mancini, M; Specchia, G; Russo, D; Iurlo, A; Bonifacio, Massimiliano; Salvucci, M; Intermesoli, T; Avanzini, P; Galimberti, S; Martino, B; Maino, E; Scortechini, Ar; Machova Polakova, K; Saglio, G; Pane, F; Rosti, G; Baccarani, M; Cavo, M; Martinelli, G.
BLAST: A Confirmatory, Single-Arm, Phase 2 Study of Blinatumomab, a Bispecific T-Cell Engager (BiTE®) Antibody Construct, in Patients with Minimal Residual Disease B-Precursor Acute Lymphoblastic Leukemia (ALL)
2014-01-01 Nicola, Goekbuget; Hervé, Dombret; Bonifacio, Massimiliano; Albrecht, Reichle; Carlos, Graux; Violaine, Havelange; Eike C., Buss; Christoph, Faul; Monika, Bruggemann; Arnold, Ganser; Julia, Stieglmaier; Hendrik, Wessels; Vincent, Haddad; Gerhard, Zugmaier; Dirk, Nagorsen; Ralf C., Bargou
Blastic plasmacytoid dendritic cell leukemia: preliminary results of a retrospective italian multicentric study.
2011-01-01 Pagano, L; Valentini, Cg; Di Paolantonio, G; Melillo, L; Gaidano, G; Venditti, A; Specchia, G; Cattaneo, C; Pica, G; Spadea, A; D’Arco, A; Candoni, A; Rodeghiero, F; Abbadessa, A; Piccin, A; Ballerini, F; Sorasio, R; Nosari, A; Caramatti, C; Invernizzi, R; Aversa, F; Pacilli, L; Musto, P; Peli, A; Quintini, G; Forghieri, F; Facchetti, F; Pavan, L; Mannelli, F; Bonifacio, Massimiliano; Leone, G; Pulsoni, A.
CAL2 monoclonal antibody is a rapid and sensitive assay for the detection of calreticulin mutations in essential thrombocythemia and may provide prognostic informations
2016-01-01 Montemezzi, Rachele; Parisi, Alice; DE MATTEIS, Giovanna; Lippi, Giuseppe; Chilosi, Marco; Krampera, Mauro; Ambrosetti, Achille; Bonifacio, Massimiliano
CAL2 Monoclonal Antibody Is a Rapid and Sensitive Assay for the Detection of Calreticulin Mutations in Essential Thrombocythemia and May Provide Prognostic Informations
2016-01-01 Bonifacio, Massimiliano; Montemezzi, Rachele; Parisi, Alice; DE MATTEIS, Giovanna; Scaffidi, Luigi; Lippi, Giuseppe; Chilosi, Marco; Pizzolo, Giovanni; Krampera, Mauro; Ambrosetti, Achille
Clonal mast cell disorders limited to bone marrow: not a negligible disease.
2010-01-01 Bonifacio, Massimiliano; Artuso, Anna; Bonadonna, Patrizia; Perbellini, Omar; Stagnoli, C; Caruso, Beatrice; Colarossi, S; Zamo', Alberto; Schena, Donatella; Rossini, Maurizio; Pizzolo, G; Zanotti, Roberta
Combination of EUTOS score and 3-month BCR-ABL transcript level identifies a group of good-risk CML patients with favourable response to imatinib front-line.
2013-01-01 Bonifacio, Massimiliano; Tiribelli, M; Binotto, G; Calistri, E; Maino, E; Marin, L; De Marchi, F; Branca, A; Gherlinzoni, F; Semenzato, G; Fanin, R; Pizzolo, G.
Combination of EUTOS score and 3-months BCR-ABL transcript level identifies a distinct subgroup of ECP-CML patients with high risk of non optimal response and imatinib discontinuation.
2013-01-01 Binotto, G; Tiribelli, M; Bonifacio, Massimiliano; Maino, E; Calistri, E; Branca, A; De Marchi, F; Bertorelle, R; Gherlinzoni, F; Pizzolo, G; Fanin, R; Semenzato, G.
Comparison of dasatinib and nilotinib as second-line therapy after imatinib failure in chronic phase chronic myeloid leukemia patients.
2015-01-01 Tiribelli, M; Bonifacio, Massimiliano; Binotto, G; Maino, E; Calistri, E; De Marchi, F; Scaffidi, Luigi; Frison, Luca; Medeot, M; Ambrosetti, Achille; Semenzato, G; Fanin, R.
Efficacy and Safety of Ruxolitinib in Elderly Patients (> 75 years) with Myelofibrosis
2016-01-01 Roberto, Latagliata; Ambra Di, Veroli; Giuseppe, Alberto Palumbo; Bonifacio, Massimiliano; Alessandro, Andriani; Nicola, Polverelli; Malgorzata, Trawinska; Mario, Tiribelli; Barbara, Anaclerico; Giulia, Benevolo; Luca, Petriccione; Bruno, Martino; Antonia, Centra; Mariella, D'Adda; Monica, Crugnola; Francesco, Cavazzini; Micaela, Bergamaschi; Alessia, Tieghi; Adalberto, Ibatici; Costanza, Bosi; Margherita, Perricone; Marco, Montanaro; Michele, Cavo; Massimo, Breccia; Nicola, Vianelli; Francesca, Palandri
Epidemiology of mastocytosis in adults based on a multidisciplinary diagnostic approach.
2013-01-01 Bonifacio, Massimiliano; Artuso, Anna; Bonadonna, Patrizia; Schena, Donatella; Rossini, Maurizio; Perbellini, Omar; Zamo', Alberto; De Matteis, G; Carli, G; Maniscalco, F; Pizzolo, G; Zanotti, Roberta
EUTOS Score Identifies Cases with Poor Outcome in Patients with Early Chronic Phase Chronic Myeloid Leukemia, Though Not Predictive for Optimal Response to Imatinib
2012-01-01 Mario, Tiribelli; Bonifacio, Massimiliano; Elisabetta, Calistri; Gianni, Binotto; Elena, Maino; Luciana, Marin; Guardalben, Emanuele; Antonio, Branca; Filippo, Gherlinzoni; Gianpietro, Semenzato; Renato, Bassan; Giovanni, Pizzolo; Renato, Fanin
EUTOS Score Predicts Optimal Response To Imatinib According To The Revised ELN Recommendations Better Than Sokal Score: A Study From The “Gruppo Triveneto LMC”
2013-01-01 Mario, Tiribelli; Bonifacio, Massimiliano; Gianni, Binotto; Elisabetta, Calistri; Elena, Maino; Roberta, Zanotti; Antonio, Branca; Marta, Medeot; Gianpietro, Semenzato; Giovanni, Pizzolo; Renato, Fanin
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A critical comparison of Sokal, Euro, and Eutos risk scores in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors. | 1-gen-2015 | Baccarani, M; Castagnetti, F; Gugliotta, G; Breccia, M; Iurlo, A; Levato, L; Abruzzese, A; Stagno, F; Bonifacio, Massimiliano; Gozzini, A; Pregno, P; Binotto, G; Annunziata, M; Galieni, P; Fava, C; Bocchia, M; Gobbi, M; Russo, D; Specchia, G; Soverini, S; Alimena, G; Martinelli, G; Pane, F; Saglio, G; Rosti, G. | |
| A simple score predicts clonal mast cell disorders in patients with systemic reactions to Hymenoptera venom without skin lesions | 1-gen-2013 | Bonifacio, Massimiliano; Bonadonna, Patrizia; Caimmi, C; Carli, G; Artuso, Anna; Lombardo, C; Perbellini, Omar; de Matteis, G; Pizzolo, G; Zanotti, Roberta | |
| A study of the crosstalk between CD30 and CXCR4 | 1-gen-2008 | Bonifacio, Massimiliano; Rigo, Antonella; Pizzolo, Giovanni; Vinante, Fabrizio | |
| A Survey on Clinical and Biological Characteristic and Therapy Management of an Italian Series of 455 Adult Patients with Systemic Mastocytosis on Behalf of Italian Registry of Mastocytosis | 1-gen-2014 | Lisa, Pieri; Bonadonna, Patrizia; Chiara, Elena; Cristina, Papayannidis; Federica Irene, Grifoni; Michela, Rondoni; Stefania, Girlanda; Marina, Mauro; Diomira, Magliacane; Elena Maria, Elli; Maria Loredana, Iorno; Maurizio, Severino; Fabio, Almerigogna; Federica, Scarfì; Bonifacio, Massimiliano; Perbellini, Omar; Artuso, Anna; Simona, Soverini; Caterina De, Benedittis; Simona, Muratori; Luisa, Lunardon; Vittoria, Cova; Gabriele, Cortellini; Alberto, Bosi; Agostino, Cortelezzi; Giovanni, Martinelli; Massimo, Triggiani; Serena, Merante; Alessandro Maria, Vannucchi; Zanotti, Roberta | |
| ALK-positive anaplastic large cell lymphoma with PAX-5 expression: report of a case | 1-gen-2011 | Zamo', Alberto; Munari, Enrico; Bertolaso, Anna; Bonifacio, Massimiliano; Chilosi, Marco | |
| Back to life – Living, treating, managing myelofibrosis: the burden of illness for patients and their families | 1-gen-2014 | Marini, Mg; Cappuccio, A; Abruzzese, A; Carella, A; Lunghi, M; Loiacono, I; Palumbo, G; Bonifacio, Massimiliano; Cilloni, D; Iurlo, A; Andriani, A; Benevolo, G; Minoia, C; Turri, D; Elli, Em; Falcone, Ap; Anaclerico, B; Traficante, A; Di Renzo, N; Tiribelli, M; Calistri, E; Zambello, R; Spinosa, C; Riccò, A; Palandri, F; Raucci, L; Martino, B; Annunziata, M; D’Alosio, M; Liberati, Am; Caocci, G; Maffioli, M; Breccia, M; Pugliese, N; Betti, S; Giglio, G; Reale, L. | |
| BCR-ABL fusion transcript b2a2 is associated with a higher risk of non-optimal early response in CP-CML patients treated with standard dose imatinib: a study from Gruppo Triveneto LMC. | 1-gen-2016 | G., Binotto; M., Tiribelli; Bonifacio, Massimiliano; L., Frison; M., Narbergoj; F., De Marchi; Scaffidi, Luigi; M., Medeot; E., Maino; E., Calistri; A., Bonalumi; Krampera, Mauro; Ambrosetti, Achille; R., Fanin; G., Semenzato | |
| BCR-ABL mutations in chronic myeloid leukemia (CML) patients (pts) with failure and warning to first- and second-lline tyrosine kinase inhibitor (TKI) therapy: what is the advantage of Next-Generation Sequencing (NGS) over conventional sequencing? | 1-gen-2015 | Soverini, S; De Benedittis, C; Castagnetti, F; Gugliotta, G; Mancini, M; Specchia, G; Russo, D; Iurlo, A; Bonifacio, Massimiliano; Salvucci, M; Intermesoli, T; Avanzini, P; Galimberti, S; Martino, B; Maino, E; Scortechini, Ar; Machova Polakova, K; Saglio, G; Pane, F; Rosti, G; Baccarani, M; Cavo, M; Martinelli, G. | |
| BLAST: A Confirmatory, Single-Arm, Phase 2 Study of Blinatumomab, a Bispecific T-Cell Engager (BiTE®) Antibody Construct, in Patients with Minimal Residual Disease B-Precursor Acute Lymphoblastic Leukemia (ALL) | 1-gen-2014 | Nicola, Goekbuget; Hervé, Dombret; Bonifacio, Massimiliano; Albrecht, Reichle; Carlos, Graux; Violaine, Havelange; Eike C., Buss; Christoph, Faul; Monika, Bruggemann; Arnold, Ganser; Julia, Stieglmaier; Hendrik, Wessels; Vincent, Haddad; Gerhard, Zugmaier; Dirk, Nagorsen; Ralf C., Bargou | |
| Blastic plasmacytoid dendritic cell leukemia: preliminary results of a retrospective italian multicentric study. | 1-gen-2011 | Pagano, L; Valentini, Cg; Di Paolantonio, G; Melillo, L; Gaidano, G; Venditti, A; Specchia, G; Cattaneo, C; Pica, G; Spadea, A; D’Arco, A; Candoni, A; Rodeghiero, F; Abbadessa, A; Piccin, A; Ballerini, F; Sorasio, R; Nosari, A; Caramatti, C; Invernizzi, R; Aversa, F; Pacilli, L; Musto, P; Peli, A; Quintini, G; Forghieri, F; Facchetti, F; Pavan, L; Mannelli, F; Bonifacio, Massimiliano; Leone, G; Pulsoni, A. | |
| CAL2 monoclonal antibody is a rapid and sensitive assay for the detection of calreticulin mutations in essential thrombocythemia and may provide prognostic informations | 1-gen-2016 | Montemezzi, Rachele; Parisi, Alice; DE MATTEIS, Giovanna; Lippi, Giuseppe; Chilosi, Marco; Krampera, Mauro; Ambrosetti, Achille; Bonifacio, Massimiliano | |
| CAL2 Monoclonal Antibody Is a Rapid and Sensitive Assay for the Detection of Calreticulin Mutations in Essential Thrombocythemia and May Provide Prognostic Informations | 1-gen-2016 | Bonifacio, Massimiliano; Montemezzi, Rachele; Parisi, Alice; DE MATTEIS, Giovanna; Scaffidi, Luigi; Lippi, Giuseppe; Chilosi, Marco; Pizzolo, Giovanni; Krampera, Mauro; Ambrosetti, Achille | |
| Clonal mast cell disorders limited to bone marrow: not a negligible disease. | 1-gen-2010 | Bonifacio, Massimiliano; Artuso, Anna; Bonadonna, Patrizia; Perbellini, Omar; Stagnoli, C; Caruso, Beatrice; Colarossi, S; Zamo', Alberto; Schena, Donatella; Rossini, Maurizio; Pizzolo, G; Zanotti, Roberta | |
| Combination of EUTOS score and 3-month BCR-ABL transcript level identifies a group of good-risk CML patients with favourable response to imatinib front-line. | 1-gen-2013 | Bonifacio, Massimiliano; Tiribelli, M; Binotto, G; Calistri, E; Maino, E; Marin, L; De Marchi, F; Branca, A; Gherlinzoni, F; Semenzato, G; Fanin, R; Pizzolo, G. | |
| Combination of EUTOS score and 3-months BCR-ABL transcript level identifies a distinct subgroup of ECP-CML patients with high risk of non optimal response and imatinib discontinuation. | 1-gen-2013 | Binotto, G; Tiribelli, M; Bonifacio, Massimiliano; Maino, E; Calistri, E; Branca, A; De Marchi, F; Bertorelle, R; Gherlinzoni, F; Pizzolo, G; Fanin, R; Semenzato, G. | |
| Comparison of dasatinib and nilotinib as second-line therapy after imatinib failure in chronic phase chronic myeloid leukemia patients. | 1-gen-2015 | Tiribelli, M; Bonifacio, Massimiliano; Binotto, G; Maino, E; Calistri, E; De Marchi, F; Scaffidi, Luigi; Frison, Luca; Medeot, M; Ambrosetti, Achille; Semenzato, G; Fanin, R. | |
| Efficacy and Safety of Ruxolitinib in Elderly Patients (> 75 years) with Myelofibrosis | 1-gen-2016 | Roberto, Latagliata; Ambra Di, Veroli; Giuseppe, Alberto Palumbo; Bonifacio, Massimiliano; Alessandro, Andriani; Nicola, Polverelli; Malgorzata, Trawinska; Mario, Tiribelli; Barbara, Anaclerico; Giulia, Benevolo; Luca, Petriccione; Bruno, Martino; Antonia, Centra; Mariella, D'Adda; Monica, Crugnola; Francesco, Cavazzini; Micaela, Bergamaschi; Alessia, Tieghi; Adalberto, Ibatici; Costanza, Bosi; Margherita, Perricone; Marco, Montanaro; Michele, Cavo; Massimo, Breccia; Nicola, Vianelli; Francesca, Palandri | |
| Epidemiology of mastocytosis in adults based on a multidisciplinary diagnostic approach. | 1-gen-2013 | Bonifacio, Massimiliano; Artuso, Anna; Bonadonna, Patrizia; Schena, Donatella; Rossini, Maurizio; Perbellini, Omar; Zamo', Alberto; De Matteis, G; Carli, G; Maniscalco, F; Pizzolo, G; Zanotti, Roberta | |
| EUTOS Score Identifies Cases with Poor Outcome in Patients with Early Chronic Phase Chronic Myeloid Leukemia, Though Not Predictive for Optimal Response to Imatinib | 1-gen-2012 | Mario, Tiribelli; Bonifacio, Massimiliano; Elisabetta, Calistri; Gianni, Binotto; Elena, Maino; Luciana, Marin; Guardalben, Emanuele; Antonio, Branca; Filippo, Gherlinzoni; Gianpietro, Semenzato; Renato, Bassan; Giovanni, Pizzolo; Renato, Fanin | |
| EUTOS Score Predicts Optimal Response To Imatinib According To The Revised ELN Recommendations Better Than Sokal Score: A Study From The “Gruppo Triveneto LMC” | 1-gen-2013 | Mario, Tiribelli; Bonifacio, Massimiliano; Gianni, Binotto; Elisabetta, Calistri; Elena, Maino; Roberta, Zanotti; Antonio, Branca; Marta, Medeot; Gianpietro, Semenzato; Giovanni, Pizzolo; Renato, Fanin |